Anke Niedernberg
Corporate Officer/Principal presso ADVANZ PHARMA CORP. LIMITED
Posizioni attive di Anke Niedernberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01/10/2021 | - |
Storia della carriera di Anke Niedernberg
Precedenti posizioni note di Anke Niedernberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
HgCapital Beratungs GmbH & Co. KG | Investitore di Private Equity | 01/01/2008 | 01/01/2010 |
Statistiche
Distribuzione geografica
Germania | 2 |
Regno Unito | 2 |
Posizioni
Private Equity Investor | 1 |
Corporate Officer/Principal | 1 |
Settori
Finance | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
HgCapital Beratungs GmbH & Co. KG | Finance |
Advanz Pharma Corp. Ltd.
Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Anke Niedernberg
- Esperienza